Strongyloidiasis: prevalence, risk factors, clinical and laboratory features among diarrhea patients in Ibadan Nigeria

Abstract

Strongyloidiasis is a parasitic infection caused by Strongyloides stercoralis. The infection is usually mild or asymptomatic in normal immunocompetent individuals, but could be very severe or even fatal due to hyper infection in individuals who are immunosuppressed. This study aimed at determining the prevalence, risk factors and features of strongyloidiasis among diarrhea patients in Ibadan. This is a descriptive cross-sectional study of diarrhea patients from a teaching hospital, three major government hospitals and one mission hospital in Ibadan. Self administered questionnaire, clinical assessment and laboratory investigations were used to confirm health status and presence of S. stercoralis. Diagnosis was made by microscopic examination of stool in saline preparation and formol-ether concentration. One thousand and ninety patients, (562 (51.6%) males and 528 (48.4%) females) consisting 380 (34.9%) children and 710 (65.1%) adults who had diarrhea were studied. The prevalence rate for the parasite among diarrhea patients was 3.0%. While the risk factor for infection remains contact with contaminated soil, malnutrition, steroid therapy, HIV/AIDS, lymphomas, tuberculosis, and chronic renal failure. Others are maleness, institutionalism and alcoholism. Predominant clinical presentations are abdominal pain, chronic diarrhea, and bloating and weight loss. Strongyloides stercoralis should be considered in diarrhea patients who are either malnourished or immunosuppressed.

Keywords: Strongyloidiasis, prevalence, diarrhea, risk factors, features, Nigerians

Résumé
La strongyloidiose est une infection parasitaire cause par les Strongyloides stercorale. L’infection est habituellement aigue ou asymptomatique chez les individus normaux et immunocompétent, mais pourrait être sévère ou même fatale due a hyper infection des individus qui sont immunodeficient. Cette étude descriptive a pour but de déterminer la prévalence, les facteurs a risqué et les caractéristiques de la strongyloidiase parmi les patients diarrhéiques dans trois centres hospitaliers majeurs et un hôpital missionnaire a Ibadan. Des questionnaires structures, une évaluation Clinique et des tests de laboratoire étaient utilises pour confirmer le statut de sante et la présence du S. stercorale. Le diagnostic était fait par examination microscopique des selles dans une préparation d’eau salée en plus d’une concentration de formol-éther. Cent quatre vingt dix patients, (562 (51.6%) males et 528 (48.4%) femelles) comprenant 380 (34.9%) enfants et 710 (65.1%) adultes qui avaient des diarrhées étaient étudiés. La prévalence des parasites parmi les cas de diarrhées était de 3.0%. Tandis que le facteur a risque d’infection parasitaire demeurait la contamination du sol, autres facteurs a risque possibles for de cette maladie inclut la malnutrition, le traitement a l’aide des stéroïdes, VIH/SIDA, lymphomes, tuberculose, et la défaillance chronique rénale. D’autres facteurs sont la masculinité, institutionnalisme et alcoolisme. Les signes cliniques prédominant étaient les douleurs abdominales, diarrhées chroniques, et la perte de poids. La strongyloide stercorale pourrait être considéré chez les cas de diarrhées qui sont soit malnouris ou immunodeficient.

Correspondence: Dr. H.O. Dada-Adegbola, Department of Medical Microbiology and Parasitology, University College Hospital, Ibadan, Nigeria. E-mail: dadaadegbola@yahoo.com, hodada-adegbola@comui.edu.ng

pdf (engelska)

Referenser

Rojas R.A.M: Pathology of protozoan and helminthic diseases, Baltimore, Williams and Wilkins, 1971, p. 713.

Purtilo D.T, Meyers W.M and Connor D.H: Fatal strongyloidiasis in immunosuppressed patients. Am. J. Med. 1974; 56: 488 – 493.

Al Samman M, Haque S and Long J.D. Strongyloidiasis colitis; a case report and review of the literature. Journal of Clinical Gastroentorology, 1999; 28, (1) 77-80.

Devault G.A, Brown S.T, Montoya S.F, King J.W, Rohr M.S, and McDonald J.C: transplantation 1982; 34: 220 – 221. Disseminated strongyloidiasis complicating acute renal allograft rejection

Hakim S.Z and Genta R.M: Fatal srongyloidiais in a Vietnam veteran. Arch. Pathol. 1986; 110: 809 – 812.

Smallman L.A, Young J.A, Shortland-Webb W.R, Carey M.P and Michael J: Strongyloides stercoralis hyperinfestation syndrome with E. coli meningitis: report of two cases. J. Clin. Pathol. 1986; 39: 366 – 370.

Cuni L.J, Rosner F and Chawla S.K: Fatal strongyloidiasis in immunosuppressed patients. N. Y. State J. Med. 1977; 77: 2109 – 2113.

Leipman M.: Disseminated Strongyloides stercoralis. A complication of immunosuppression. J.A.M.A. 1975; 231: 387 – 388.

O’ Brien W. Intestinal malabsorption in acute infection with Strongyloides stercoralis. Trans. R. Soc. Trop. Med. Hyg. 1975; 69: 11.

Smith S.B., Schwartzman M., Mencia L.F., Blum E.B., Krogstad D., Nitzkin J. and Healy G.R.: Fatal disseminated strongyloidiasis presenting as acute abdominal distress in an urban child. J. Paediatr. 1977; 91: 607-609.

Milder J.E., Walzer P.D, Kilgore G., Rutherford I. and Klein M.: Clinical features of Strongyloides stercoralis infection in an endemic area of the United States. Gastroentrology. 1981; 80, 1481-1488.

Gbakima A.A and Sahr F.: Intestinal parasitic infections among rural farming communities in Eastern Sierra Leone. Afr. J. Med. Med. Sci. 1995; 24, 195-200.

Onadeko M.O and Ladipo O.A.: Intestinal parasitic infestation in rural communities: a focus for primary health care in Nigeria. Afr. J. Med. and Med. Sci. 1989; 18: 289 – 294.

Hinman, E.H. A study of eighty-five cases of Strongyloides stercoralis infection, with special reference to abdominal pain. Trans. R. Soc. Trop. Med. Hyg. 1937; 30:531-538.

Faust E.C: Human strongyloidiasis in Panama. Amer. J. Hyg. 1931; 14: 203.

Bras G., Richards R.C., Irvine R.A., Milner P.F.A and Ragbeer M.M.S. Infection with Strongyloides stercoralis in Jamaica. Lancet 1964; 2: 1257-1260.

Willis A.J.P. and Nwokolo C.: Steroid therapy and strongyloidiasis. Lancet 1966; 1: 1396.

Yoeli M, Most H, Berman H.H et al: The problem of strongyloidiasis among the mentally retarded in institutions. Trans. R. Soc. Trop. Med. Hyg. 1963; 57: 336 – 345.

Igra-siegman, Y. Kapila R., Sen P., Kaminski Z.C. and Louria D.B. Syndrome of hyperinfection with Strongyloides stercoralis. Rev. Infect. Dis. 1981; 3: 397-407.

Pelletier L.L.: Chronic strongyloidiasis in World War II Far East ex-prisoners of War. Am. J. Trop. Med. Hyg. 1984; 33: 55-61.

Boram, L.H., Keller, K.F., Justus, D.E. and Collins, J.P. Strongyloidiasis in immunosuppressed patients. Am. J. Clin. Pathol. 1981; 76: 778-781. .

Rivera E, Maldonado N, Velez-Garcia E, Grillo A.J and Malaret G.: Hyperinfection syndrome with Strongyloides stercoralis. Ann. Intern. Med. 1970; 72: 199 – 204.

Yim Y., Kikkawa Y., Tanowitz H. and Wittner M. Fatal strongyloidiasis in Hodgkin’s disease after immunosuppressive therapy. J. Trop. Med. Hyg. 1970; 73: 245-249.

Rogers W.A Jr. and Nelson B.: Strongyloidiasis and malignant lymphoma: “Opportunistic infection” by a nematode. J.A.M.A. 1966; 195: 685-687.

Civantos F. and Robinson M.J. Fatal strongyloidiasis following corticosteroid therapy. Am. J. Dig. Dis. 1969; 14: 643 – 651.

Onile B., Komolafe F. and Oladiran B. Severe strongyloidiasis presenting as occult gastrointestinal tract malignancy. Ann. Trop. Med. Parasitol. 1985; 79(3): 301-304.

Dee A., Batenburg P.L, Umar H.M, Menon R.S and Verweij J.: Strongyloides stercoralis associated with a bleeding gastric ulcer. Gut. 1990; 31: 1414 – 1415.

Milner P.F, Irvine R.A, Barton C.J, Bras G and Richards R.: Intestinal malabsorption in Strongyloides stercoralis infestation. Gut. 1965; 6: 574 – 581.

Neefe L.I., Pinilla O., Garagusi V.F. and Bauer H. Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am. J. Med. 1973; 55: 832-838.

Davidson RA. Strongylodiaisis: a presentation of 63 cases. N.C. Med. J. 1982; 43: 23 – 25.